Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes

Diabet Med. 2003 Jun;20(6):491-4. doi: 10.1046/j.1464-5491.2003.00951.x.

Abstract

Aims: To explore whether the coding region of the islet amyloid polypeptide (IAPP) gene contains genetic variants associated with Type 2 diabetes and whether a previously reported association of the promoter variant -132g-->a with Type 2 diabetes could be reproduced in Danish Caucasians.

Methods: The coding region was analyzed using single strand conformation polymorphism (SSCP) and heteroduplex analysis in 192 Type 2 diabetic patients. Restriction fragment length polymorphism (RFLP) was employed to screen for the promoter variant in 414 Type 2 diabetic patients and 182 glucose-tolerant control subjects.

Results: The SSCP analysis identified an IVS+75a-->g variant in two patients. The frequency of heterozygous carriers of the promoter variant in the case-control study was 4.1% (17/414) and 7.1% (13/182), respectively. Odds ratio of the prevalence of Type 2 diabetes in carriers compared with non-carriers was estimated to be 0.47 (95% confidence interval 0.19, 1.15).

Conclusion: Neither variability in the coding region of the IAPP gene nor the -132g-->a promoter variant was associated with Type 2 diabetes among the studied Danish Caucasians.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / genetics*
  • Base Sequence
  • Diabetes Mellitus, Type 2 / genetics*
  • Female
  • Genotype
  • Heteroduplex Analysis / methods
  • Humans
  • Islet Amyloid Polypeptide
  • Male
  • Middle Aged
  • Mutation / genetics
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single-Stranded Conformational
  • Promoter Regions, Genetic / genetics

Substances

  • Amyloid
  • Islet Amyloid Polypeptide